Arnaud D. Hauer

861 total citations
17 papers, 651 citations indexed

About

Arnaud D. Hauer is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Arnaud D. Hauer has authored 17 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Epidemiology. Recurrent topics in Arnaud D. Hauer's work include Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Cell Adhesion Molecules Research (3 papers). Arnaud D. Hauer is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Cell Adhesion Molecules Research (3 papers). Arnaud D. Hauer collaborates with scholars based in Netherlands, United States and United Kingdom. Arnaud D. Hauer's co-authors include Johan Kuiper, Paul de Vos, Theo J.C. van Berkel, Gijs H.M. van Puijvelde, Eva J.A. van Wanrooij, Catherine Uyttenhove, Jacques Van Snick, Jean‐Christophe Renauld, Vincent Stroobant and Th.J.C. van Berkel and has published in prestigious journals such as Circulation, Arteriosclerosis Thrombosis and Vascular Biology and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Arnaud D. Hauer

16 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnaud D. Hauer Netherlands 11 451 172 166 95 93 17 651
Eva J.A. van Wanrooij Netherlands 13 579 1.3× 304 1.8× 209 1.3× 114 1.2× 146 1.6× 14 881
S Gupta India 6 665 1.5× 173 1.0× 261 1.6× 119 1.3× 99 1.1× 11 787
Sonia Tolani United States 9 417 0.9× 211 1.2× 142 0.9× 59 0.6× 127 1.4× 10 786
Huaxi Xu China 10 350 0.8× 141 0.8× 122 0.7× 92 1.0× 86 0.9× 12 613
Aditi Varthaman France 12 447 1.0× 167 1.0× 191 1.2× 19 0.2× 84 0.9× 15 740
Marta Amaral Portugal 12 272 0.6× 121 0.7× 59 0.4× 83 0.9× 153 1.6× 24 541
Helene Hartwig Germany 8 329 0.7× 161 0.9× 99 0.6× 24 0.3× 99 1.1× 12 504
Lakhvir K. Assi United Kingdom 12 309 0.7× 337 2.0× 57 0.3× 85 0.9× 62 0.7× 17 737
Anissa A. Widjaja Singapore 16 208 0.5× 229 1.3× 175 1.1× 29 0.3× 176 1.9× 29 752
Kong Xiantao China 11 189 0.4× 54 0.3× 64 0.4× 43 0.5× 56 0.6× 33 360

Countries citing papers authored by Arnaud D. Hauer

Since Specialization
Citations

This map shows the geographic impact of Arnaud D. Hauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud D. Hauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud D. Hauer more than expected).

Fields of papers citing papers by Arnaud D. Hauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud D. Hauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud D. Hauer. The network helps show where Arnaud D. Hauer may publish in the future.

Co-authorship network of co-authors of Arnaud D. Hauer

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud D. Hauer. A scholar is included among the top collaborators of Arnaud D. Hauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud D. Hauer. Arnaud D. Hauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Vliet, Mariska van, Jan J.J. Aalberts, Arnaud D. Hauer, et al.. (2025). Assessment of photoplethysmography-based blood pressure determinations during long-term and short-term remote cardiac monitoring: the RECAMO study. European Heart Journal - Digital Health. 6(4). 763–771.
2.
Vliet, Mariska van, Jan J.J. Aalberts, Arnaud D. Hauer, et al.. (2025). Ambulatory atrial fibrillation detection and quantification by wristworn AI device compared to standard holter monitoring. npj Digital Medicine. 8(1). 177–177. 4 indexed citations
3.
Hauer, Arnaud D., et al.. (2024). Is CRT Optimization Obsolete? A Referral Center’s Experience. Reviews in Cardiovascular Medicine. 25(2). 63–63. 1 indexed citations
4.
Réant, Patricia, Arnaud D. Hauer, Silvia Castelletti, et al.. (2015). Epicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy. International journal of cardiac imaging. 32(4). 593–601. 16 indexed citations
5.
Korporaal, Suzanne J.A., Illiana Meurs, Arnaud D. Hauer, et al.. (2010). Deletion of the High-Density Lipoprotein Receptor Scavenger Receptor BI in Mice Modulates Thrombosis Susceptibility and Indirectly Affects Platelet Function by Elevation of Plasma Free Cholesterol. Arteriosclerosis Thrombosis and Vascular Biology. 31(1). 34–42. 59 indexed citations
6.
Hauer, Arnaud D., et al.. (2009). Effect of natural killer T cell activation on initiation of atherosclerosis. Thrombosis and Haemostasis. 102(8). 223–230. 39 indexed citations
7.
Hauer, Arnaud D., Kim L. L. Habets, Eva J.A. van Wanrooij, et al.. (2008). Vaccination against TIE2 reduces atherosclerosis. Atherosclerosis. 204(2). 365–371. 25 indexed citations
8.
Habets, Kim L. L., et al.. (2008). A Vaccine Against Atherosclerosis: Myth Or reality?. Future Cardiology. 4(2). 125–133. 3 indexed citations
9.
Brüggemann, Lois W., Dirkje W. Sommeijer, Arnaud D. Hauer, et al.. (2007). Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice. Blood Coagulation & Fibrinolysis. 18(7). 627–636. 10 indexed citations
10.
Kuiper, Johan, et al.. (2007). Immunomodulation of the inflammatory response in atherosclerosis. Current Opinion in Lipidology. 18(5). 521–526. 33 indexed citations
11.
Hauer, Arnaud D., Gijs H.M. van Puijvelde, Paul de Vos, et al.. (2007). Vaccination Against VEGFR2 Attenuates Initiation and Progression of Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 27(9). 2050–2057. 67 indexed citations
12.
Hauer, Arnaud D.. (2006). [Probiotics in allergic diseases of childhood].. PubMed. 148(35-36). 34–6. 2 indexed citations
13.
Hauer, Arnaud D., Gijs H.M. van Puijvelde, Vincent van Weel, et al.. (2006). Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Vascular Pharmacology. 45(3). e5–e5. 5 indexed citations
14.
Puijvelde, Gijs H.M. van, Arnaud D. Hauer, Paul de Vos, et al.. (2006). Induction of Oral Tolerance to Oxidized Low-Density Lipoprotein Ameliorates Atherosclerosis. Circulation. 114(18). 1968–1976. 139 indexed citations
15.
Hauer, Arnaud D., Catherine Uyttenhove, Paul de Vos, et al.. (2005). Blockade of Interleukin-12 Function by Protein Vaccination Attenuates Atherosclerosis. Circulation. 112(7). 1054–1062. 145 indexed citations
16.
Wanrooij, Eva J.A. van, H. Kevin Happe, Arnaud D. Hauer, et al.. (2005). HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 25(12). 2642–2647. 76 indexed citations
17.
Michon, Ingrid, Arnaud D. Hauer, Jan H. von der Thüsen, et al.. (2002). Targeting of peptides to restenotic vascular smooth muscle cells using phage display in vitro and in vivo. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1591(1-3). 87–97. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026